fda ruling on glp 1 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Fmr. FDA Commissioner weighs in

GLP-1 receptor agonists work partly by slowing gastric emptying, which helps people feel fuller longer and reduces blood sugar spikes after meals

Thus, a loss of estradiol post-menopause, may contribute to the development of obesity, and systemic and cerebral insulin resistance ( This review describes the physiological and pathophysiological mechanisms that govern the actions of estradiol on food intake and energy expenditure during the menstrual cycle ( Menstrual cycle and appetite control: Implications for weight regulation The CNS, particularly the hypothalamus, plays a key role in homeostatic feeding

References: Nauck, M

The lag is especially acute for peptides: for instance, the Wegovy pill approved in late 2025 is made end-to-end in North Carolina ( [16] ), but its supply depends on scaling semaglutide API production first

Your treatment plan is then customized to fit your individual needs

As I wrote about here, their ads trivialize the use of GLP-1s and cross a line into irresponsible promotion